Scientific Director, Biologics Group @ Catalent
Jingtao is a Scientific Director in the Biologics Group at Catalent Pharma Solutions, responsible for developing new technical capabilities and product solutions to solve clients’ pressing pharmaceutical problems. His current focus is introducing, developing, and establishing development and manufacturing capabilities in LNP for mRNA modalities within Catalent. Prior to Catalent, he was a principal scientist in the Department of Pharmaceutical Sciences at Merck & Co., Inc. (Kenilworth, NJ), discovering and developing drug products of small molecule, peptide, oligonucleotide/siRNA, biologics, mRNA, LNPs, and nano-therapeutics. He received his Ph.D. in Chemical Engineering from the University of Wisconsin-Madison and has more than more than 16 years’ experience in pharmaceutical industry.